Anthera Pharmaceuticals
Delaware corporation
Anthera Pharmaceuticals, Inc. is an American biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases. Liprotamase (Sollpura), Anthera's leading drug candidate which is being developed for exocrine pancreatic insufficiency (EPI) is currently in Phase 3 clinical trials, and A-623 (Blisibimod) for the treatment of IgA nephropathy is currently in Phase 2 clinical trial.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 80 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
0
confidence 70 % · metrics-v1
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
0
confidence 67 % · cci-v1
6 active sensors·9 observations·0 historical changes·0 structured events·historical coverage 95 %·observed since 2026-09-13
Compare Anthera Pharmaceuticals with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies